Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free HIMS Stock Alerts

Hims & Hers Health (HIMS) Short Interest Ratio & Short Volume

Hims & Hers Health logo
$29.46 +0.18 (+0.61%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$29.36 -0.10 (-0.32%)
As of 09/25/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Hims & Hers Health Short Interest Overview

As of September 15, 2026, Hims & Hers Health (HIMS) had a short interest of 52.92 million shares sold short, representing 25.71% of the public float. This marks a -3.69% decrease in short interest since the prior report. The short interest ratio (days to cover) is 6.1, meaning it would take 6.1 days of the average trading volume of 9.41 million shares to cover all short positions.

Current Short Interest
52,920,443 shares
Previous Short Interest
54,945,417 shares
Change Vs. Previous Month
-3.69%
Dollar Volume Sold Short
$1.48 billion
Short Interest Ratio
6.1 Days to Cover
Last Record Date
September 15, 2026
Outstanding Shares
233,310,000 shares
Short Percent of Float
25.71%
Today's Trading Volume
8,189,008 shares
Average Trading Volume
9,406,055 shares
Today's Volume Vs. Average
87%
Short Selling Hims & Hers Health?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Hims & Hers Health and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

HIMS Short Interest Over Time

HIMS Days to Cover Over Time

HIMS Percentage of Float Shorted Over Time

Hims & Hers Health Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202652,920,443 shares $1.48 billion -3.7%25.7%6.13 $27.88
8/31/202654,945,417 shares $1.62 billion -6.4%26.7%4.33 $29.56
8/14/202658,674,597 shares $1.65 billion -5.7%28.5%4.49 $28.15
7/31/202662,215,733 shares $1.73 billion +1.3%30.5%3.71 $27.79
7/15/202661,410,121 shares $2.29 billion +0.4%30.1%4.52 $37.24
6/30/202661,166,806 shares $2.11 billion -6.6%29.9%3.23 $34.54
6/15/202665,472,703 shares $1.97 billion +4.6%32.1%3.53 $30.10
5/29/202662,610,734 shares $1.64 billion -1.2%30.7%3.14 $26.12
5/15/202663,372,020 shares $1.59 billion +0.3%31.5%2.45 $25.06
4/30/202663,160,154 shares $1.72 billion -9.5%31.4%1.48 $27.27
4/15/202669,774,819 shares $1.71 billion -2.2%34.2%3.01 $24.50
3/31/202671,359,926 shares $1.48 billion -14.3%34.9%2.5 $20.75
3/13/202683,286,092 shares $2.06 billion -2.0%44.4%1.31 $24.74
2/27/202684,964,491 shares $1.23 billion +4.9%45.3%2.58 $14.51
2/13/202681,010,101 shares $1.32 billion +5.5%39.7%1.72 $16.31
1/30/202676,761,792 shares $2.08 billion +6.2%41.0%4.37 $27.15
1/15/202672,251,095 shares $2.26 billion +7.7%38.6%4.4 $31.21
12/31/202567,096,243 shares $2.18 billion +3.5%35.8%6.19 $32.45
12/15/202564,816,789 shares $2.35 billion -3.7%34.6%4.63 $36.29
11/28/202567,327,436 shares $2.44 billion -0.3%35.9%3.31 $36.29
11/14/202567,552,266 shares $2.51 billion -3.7%36.1%1.97 $37.09
10/31/202570,158,018 shares $3.20 billion +4.9%37.5%2.63 $45.55
10/15/202566,880,000 shares $4.20 billion -5.8%36.0%2.2 $62.79
9/30/202571,010,000 shares $4.03 billion +6.7%N/A2.4 $56.71
9/15/202566,530,000 shares $3.59 billion -10.9%N/A2 $54.02
8/31/202574,640,000 shares $3.16 billion +6.3%38.3%2.1 $42.36
8/15/202570,220,000 shares $3.24 billion +8.7%N/A1.8 $46.09
7/31/202564,590,000 shares $4.27 billion -1.1%33.4%1.5 $66.18
7/15/202565,300,000 shares $3.29 billion -4.5%N/A1.4 $50.44
6/30/202568,350,000 shares $3.41 billion +10.8%35.4%1.5 $49.94
6/15/202561,690,000 shares $3.41 billion +1.3%31.9%1.4 $55.33
5/31/202560,880,000 shares $3.45 billion -2.3%33.9%1.6 $56.74
5/15/202562,340,000 shares $3.65 billion +0.1%34.7%1.7 $58.54
4/30/202562,310,000 shares $2.06 billion +2.7%N/A1.8 $33.06
4/15/202560,660,000 shares $1.79 billion +5.0%33.3%2.5 $29.49
3/31/202557,770,000 shares $1.72 billion +5.6%31.7%2.4 $29.73
3/15/202554,730,000 shares $1.81 billion +5.6%30.1%2.6 $33.10
2/28/202551,840,000 shares $2.34 billion +12.4%28.6%2.6 $45.20
2/15/202546,120,000 shares $2.79 billion -20.8%25.4%2.4 $60.41
1/31/202558,210,000 shares $2.17 billion +2.9%32.9%3.7 $37.33
Shocking new footage just released (Ad)

Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.tc pixel

Watch Gerardo Del Real's new uranium market breakdown now
1/15/202556,580,000 shares $1.57 billion +8.6%31.9%3.6 $27.81
12/31/202452,120,000 shares $1.26 billion +21.3%29.4%3.2 $24.18
12/15/202442,970,000 shares $1.29 billion +0.8%24.2%2.6 $30.02
11/30/202442,620,000 shares $1.37 billion +7.8%24.0%2.7 $32.22
11/15/202439,520,000 shares $765.11 million +16.8%22.3%2.7 $19.36
10/31/202433,840,000 shares $637.71 million +6.2%19.1%3.1 $18.85
10/15/202431,870,000 shares $726.64 million +28.7%18.3%3.2 $22.80
9/30/202424,760,000 shares $456.20 million -6.7%14.2%2.6 $18.43
9/15/202426,540,000 shares $439.77 million -5.4%16.2%3 $16.57
8/31/202428,040,000 shares $413.03 million +21.7%17.1%3 $14.73
8/15/202423,040,000 shares $362.07 million +19.6%14.0%2.2 $15.72
7/31/202419,260,000 shares $409.08 million -2.8%12.7%1.6 $21.24
7/15/202419,810,000 shares $452.46 million +12.8%13.1%1.9 $22.84
6/30/202417,560,000 shares $354.54 million +3.3%11.7%1.7 $20.19
6/15/202417,000,000 shares $403.75 million -19.7%11.3%1.8 $23.75
5/31/202421,160,000 shares $410.93 million -4.4%14.0%2.5 $19.42
5/15/202422,130,000 shares $305.62 million +20.3%14.7%2.7 $13.81
4/30/202418,390,000 shares $230.24 million +5.3%13.2%3 $12.52
4/15/202417,470,000 shares $230.95 million +34.6%12.5%3.5 $13.22
3/31/202412,980,000 shares $200.80 million +1.7%9.4%2.8 $15.47
3/15/202412,760,000 shares $186.81 million +0.9%9.2%2.9 $14.64
2/29/202412,650,000 shares $164.96 million -6.1%9.1%3.1 $13.04
2/15/202413,470,000 shares $135.37 million -6.6%10.0%4.1 $10.05
1/31/202414,420,000 shares $123.72 million -5.2%10.6%4.8 $8.58
1/15/202415,210,000 shares $130.35 million +1.1%11.2%5.3 $8.57
12/31/202315,040,000 shares $133.86 million -4.0%11.1%5.3 $8.90
12/15/202315,670,000 shares $132.33 million -7.9%11.5%6 $8.45
11/30/202317,020,000 shares $151.31 million -1.7%12.5%6.7 $8.89
11/15/202317,310,000 shares $133.63 million +2.1%12.8%7.2 $7.72
10/31/202316,960,000 shares $101.42 million -0.9%12.6%6.9 $5.98
10/15/202317,120,000 shares $107 million -3.0%12.7%6.7 $6.25
9/30/202317,640,000 shares $110.96 million +5.4%13.1%6.5 $6.29
9/15/202316,730,000 shares $105.57 million +0.5%12.4%5.9 $6.31
8/31/202316,650,000 shares $111.72 million -5.8%12.4%5.6 $6.71
8/15/202317,680,000 shares $127.03 million -21.4%13.1%5.4 $7.19
7/31/202322,480,000 shares $201.53 million -8.2%16.9%6.5 $8.97
7/15/202324,490,000 shares $216.98 million +10.9%18.4%7.7 $8.86
6/30/202322,090,000 shares $207.65 million +4.8%16.6%6.5 $9.40
6/15/202321,080,000 shares $185.50 million +3.9%15.8%6.2 $8.80
5/31/202320,280,000 shares $181.30 million -3.2%15.3%5.8 $8.94
5/15/202320,940,000 shares $225.52 million -7.0%17.0%5.4 $10.77
4/30/202322,510,000 shares $260.89 million -2.0%18.4%6.1 $11.59
4/15/202322,960,000 shares $224.09 million +2.5%18.9%6.7 $9.76
3/31/202322,410,000 shares $222.31 million +7.1%18.5%7.6 $9.92
3/15/202320,930,000 shares $188.58 million +9.8%17.3%8 $9.01
2/28/202319,060,000 shares $214.81 million +5.8%15.8%8.2 $11.27
2/15/202318,010,000 shares $180.64 million +4.4%15.9%10.5 $10.03
1/31/202317,260,000 shares $142.91 million +5.2%16.2%9.1 $8.28
1/15/202316,400,000 shares $123.49 million +1.5%15.4%9.5 $7.53
12/30/202216,160,000 shares $103.59 million No Change15.2%9.2 $6.41
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
12/15/202216,160,000 shares $111.50 million -1.8%15.2%9.2 $6.90
11/30/202216,460,000 shares $101.89 million +3.1%15.5%9.5 $6.19
11/15/202215,970,000 shares $98.85 million +21.2%15.1%9.4 $6.19
10/31/202213,180,000 shares $59.84 million -5.4%12.5%8.1 $4.54
10/15/202213,930,000 shares $66.45 million +6.5%13.2%8.9 $4.77
9/30/202213,080,000 shares $72.99 million -4.1%12.4%8.3 $5.58
9/15/202213,640,000 shares $82.25 million +2.3%12.9%7.1 $6.03
8/31/202213,340,000 shares $84.84 million +0.7%12.7%6.5 $6.36
8/15/202213,250,000 shares $95.67 million +6.6%12.6%6.3 $7.22
7/31/202212,430,000 shares $76.94 million +1.0%12.1%5.3 $6.19
7/15/202212,310,000 shares $67.83 million +4.4%12.0%5.4 $5.51
6/30/202211,790,000 shares $53.41 million +27.1%11.5%5.1 $4.53
6/15/20229,280,000 shares $37.77 million +3.3%9.1%4.1 $4.07
5/31/20228,980,000 shares $36.28 million -7.6%8.8%4.2 $4.04
5/15/20229,720,000 shares $33.53 million +12.0%9.5%4 $3.45
4/30/20228,680,000 shares $36.54 million +7.8%7.9%4 $4.21
4/15/20228,050,000 shares $40.73 million -1.8%7.3%3.5 $5.06
3/31/20228,200,000 shares $43.71 million -8.1%7.5%3.5 $5.33
3/15/20228,920,000 shares $38.71 million -13.8%8.1%3.7 $4.34
2/28/202210,350,000 shares $54.03 million +5.5%9.4%4.3 $5.22
2/15/20229,810,000 shares $47.77 million +20.2%8.9%4 $4.87
1/31/20228,160,000 shares $39.82 million +5.2%8.4%3.1 $4.88
1/15/20227,760,000 shares $41.05 million -11.2%8.0%3 $5.29
12/31/20218,740,000 shares $57.25 million -7.3%9.0%3.5 $6.55
12/15/20219,430,000 shares $59.88 million -2.3%9.7%3.8 $6.35
11/30/20219,650,000 shares $63.21 million +14.7%10.0%4 $6.55
11/15/20218,410,000 shares $68.71 million +23.5%7.9%3.4 $8.17
10/29/20216,810,000 shares $53.12 million +10.0%8.8%2.8 $7.80
10/15/20216,190,000 shares $51.75 million -3.4%8.0%2.4 $8.36
9/30/20216,410,000 shares $48.33 million +13.1%8.3%2.5 $7.54

HIMS Short Interest - Frequently Asked Questions

Short interest is the volume of Hims & Hers Health shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 52,920,443 shares of HIMS short. 25.71% of Hims & Hers Health's shares are currently sold short. Learn More on Hims & Hers Health's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HIMS shares currently have a short interest ratio of 6.1. Learn More on Hims & Hers Health's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 25.71% of Hims & Hers Health's floating shares are currently sold short.

Hims & Hers Health saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 52,920,443 shares, a decline of 3.7% from the previous total of 54,945,417 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

25.71% of Hims & Hers Health's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare services" compare to Hims & Hers Health: Guardant Health, Inc. (8.70%), Tempus AI, Inc. (20.53%), Fresenius Medical Care AG & Co. KGaA (0.51%), DaVita Inc. (6.87%), BrightSpring Health Services, Inc. (5.30%), Hinge Health Inc. (7.38%), Chemed Corporation (5.17%), RadNet, Inc. (12.95%), LifeStance Health Group, Inc. (4.41%), Billiontoone, Inc. (11.18%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.21 billion), Invesco QQQ ($46.31 billion), iShares Russell 2000 ETF ($27.98 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($9.70 billion), Canadian Natural Resources Limited ($9.42 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.53 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.79 billion), and Financial Select Sector SPDR Fund ($7.74 billion). View all of the most shorted stocks.

Short selling HIMS is an investing strategy that aims to generate trading profit from Hims & Hers Health as its price is falling. HIMS shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Hims & Hers Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HIMS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HIMS, twice per month. The most recent reporting period available is September, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like HIMS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NYSE:HIMS is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
"How Much Can I Actually Spend Each Year With $2.5M Saved?"
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Iran War WARNING: Something Just Changed
A powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...
Banyan Hill Publishing | Sponsoredtc pixel